Ad is loading...
SCVNX
Price
$42.17
Change
-$0.37 (-0.87%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

SCVNX vs VISVX

Header iconSCVNX vs VISVX Comparison
Open Charts SCVNX vs VISVXBanner chart's image
Allspring Small Company Value Inst
Price$42.17
Change-$0.37 (-0.87%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
SCVNX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SCVNX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCVNX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. SCVNX (699M). VISVX pays higher dividends than SCVNX: VISVX (1.90) vs SCVNX (0.98). SCVNX was incepted earlier than VISVX: SCVNX (14 years) vs VISVX (27 years). SCVNX is a more actively managed with annual turnover of: 87.00 vs. VISVX (16.00). VISVX has a lower initial minimum investment than SCVNX: VISVX (3000) vs SCVNX (1000000). SCVNX (30.12) and VISVX (28.71) have marching annual gain over last year. VISVX (57.32) and SCVNX (56.04) have equivalent 5 years return.
SCVNXVISVXSCVNX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years27 years-
Gain YTD14.90515.43397%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets699M57.6B1%
Annual Yield % from dividends0.981.9052%
Returns for 1 year30.1228.71105%
Returns for 3 years3.1713.2324%
Returns for 5 years56.0457.3298%
Returns for 10 years112.61108.21104%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics